A Clinical Trial of Hepalatide for Injection in Patients With Chronic Hepatitis D
Clinical trial NCT06505928 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06505928
- Sponsor
- Shanghai HEP Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-11
- Primary completion
- 2026-05-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.